Nanomedicines and Vaccines
NANO-VAC
University of Paris-Saclay
Gif-sur-Yvette, FranciaPublications in collaboration with researchers from University of Paris-Saclay (9)
2021
2020
-
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
World Allergy Organization Journal, Vol. 13, Núm. 2
2012
-
Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 81, Núm. 3, pp. 514-523
2011
-
Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery
Expert Opinion on Drug Delivery, Vol. 8, Núm. 6, pp. 721-734
2009
-
Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel
European Journal of Pharmaceutical Sciences, Vol. 38, Núm. 4, pp. 405-413
2008
-
Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 1, pp. 98-108
2002
-
In vitro antileishmanial activity of amphotericin B loaded in poly(ε-caprolactone) nanospheres
Journal of Drug Targeting, Vol. 10, Núm. 8, pp. 593-599
2000
-
Bioadhesive potential of gliadin nanoparticulate systems
European Journal of Pharmaceutical Sciences, Vol. 11, Núm. 4, pp. 333-341
-
In vitro reversion of amphotericin B resistance in Leishmania donovani by Poloxamer 188
Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 8, pp. 2190-2192